Euan Noble

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Donald Brandon, Natalia Allende Burgos et al. · The Lancet · 2023 · 267 citations · Full text

Medicine, Internal Medicine, Nephrology +9

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

Medicine, Internal Medicine, Nephrology +12

Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

Frank B. Cortazar, John L. Niles, David Jayne et al. · Kidney International Reports · 2023 · 85 citations · Full text

Medicine, Internal Medicine, Nephrology +16

The impact of automated eGFR reporting and education on nephrology service referrals

Euan Noble, David W. Johnson, Nicholas A. Gray et al. · Nephrology Dialysis Transplantation · 2008 · 78 citations · Full text

Medicine, Health Informatics, Nephrology +17

A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial

Katherine A. Barraclough, Fiona G. Brown, Carmel M. Hawley et al. · Nephrology Dialysis Transplantation · 2012 · 36 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16